Primer: Deploying Private Fund Capital Globally in Complex Regulatory Times

We are often asked how a private equity or venture capital fund should be structured if it expects to raise capital globally and invest across multiple countries.

Historically, that question was often framed primarily as a tax, securities law, domicile or investor preference question. Should the fund be Delaware or Cayman? Should there be a parallel fund? Should there be a blocker? Should certain investors come through a feeder? Will non-US investors receive US tax reporting? Will US tax-exempt investors have unrelated business taxable income (UBTI) concerns? Will there be treaty, withholding, passive foreign investment company (PFIC), controlled foreign corporation (CFC) or other tax issues?

Those questions still matter. They have not gone away.

But for global venture capital and private equity funds, especially funds investing across the US and China in technology-adjacent sectors, the question has become broader. Managers now need to think not only about where the fund is formed, but also about where the capital comes from, who controls the fund, what sectors the fund will invest in, what information investors will receive, what rights investors will have and whether the fund structure can adapt as regulatory rules change.

The practical point is simple, even if the underlying rules are complex: In today’s environment, global fund structuring is increasingly about routing capital, control, information and governance in a way that matches the regulatory profile of the fund’s strategy.

That does not mean global investing is impossible. It does not mean funds should avoid every sensitive sector. It does not mean managers should abandon US-China strategies, global technology strategies, life sciences strategies or multicountry venture strategies. It does mean that managers should be more deliberate at the time the fund is formed and launch with more agility to react in a needed way, and on a reasonable timeframe, as the years unfold.

In that way, fund documents need to anticipate the regulatory architecture the manager may need later. A manager should not be discovering, after signing a term sheet for a sensitive investment, that the fund cannot create the right parallel vehicle, exclude the right investors, make capital calls by regulatory sleeve, limit information rights, form an alternative investment vehicle (AIV) quickly, use a power of attorney to implement a pre-agreed structure or keep the wrong investors out of the wrong governance process.

In complex global strategies, capital, control, information and governance all need to tell the same story.

Start with the strategy

The first question is what the fund is trying to invest in.

A global fund investing in ordinary consumer products, furniture, apparel, restaurants, local services or basic nonsensitive manufacturing presents a very different profile from a fund investing in semiconductors, quantum computing, AI, advanced computing, cybersecurity, defense-adjacent technologies, critical infrastructure, sensitive data businesses or other sectors that governments increasingly view through a national security lens.

There is also a large middle category.

Life sciences, biotechnology, healthcare technology, AI-enabled drug discovery, clinical trial platforms, robotics, fintech, logistics, data-enabled consumer businesses and other technology-adjacent sectors may not always sit at the center of current regulatory focus. But they may still raise meaningful issues depending on the facts. A life sciences company may use AI to identify drug targets. A healthcare business may hold large amounts of personal information. A robotics company may have applications that look commercial in one context and sensitive in another. A data company may appear benign until one understands what data it holds, who its customers are and how the data could be used.

Managers should therefore think about investment strategy as a spectrum.

At one end are strategies that are highly unlikely to raise significant national security or outbound investment concerns. At the other end are strategies where regulatory structuring should be central from the beginning. In the middle are strategies that may look ordinary in some deals and sensitive in others.

The middle category is often where mistakes happen.

A manager may say, “We are not a semiconductor fund.” That may be true. But if the fund expects to invest in AI-enabled biotechnology, data-heavy healthcare platforms, robotics, cybersecurity, advanced computing infrastructure or companies with meaningful US-China technology exposure, the manager should not assume the fund is outside the relevant regimes. The answer will depend on the facts.

There is also a timing point. A closed-end private fund is not making all of its investments on the day it holds its first closing. It may invest over four, five or six years and manage its portfolio for 10, 12, 15 or more years. Regulatory focus can change during that period. Sectors that are not the focus of today’s rules may become the focus of tomorrow’s rules. A fund formed today should not be drafted only for the first deal in the pipeline.

The fund documents should be built with enough flexibility to respond to a changing regulatory environment.

Investor identity matters

The second question is who the investors are.

For global funds, this is no longer just a subscription document detail. Investor identity can affect whether particular investments are possible, whether particular investors need to be excluded, whether parallel vehicles are needed, whether information must be limited, whether side letter assurances are required and whether the fund can make certain investments without creating regulatory problems for its investors.

For US outbound investment purposes, US person investors may care deeply about whether their capital is used for certain China-related investments in sensitive sectors. Even if the fund itself is organized outside the US, a US person investing indirectly through that fund may have a legal issue if the fund makes investments that fall within the outbound investment rules and the US investor does not fit within an exception or receive an appropriate contractual assurance.

That is a critical fund formation point. The fund’s later investment activity can create a problem for the limited partner (LP).

For Committee on Foreign Investment in the United Stated (CFIUS) purposes, foreign investors can matter when a fund invests into US businesses, particularly US businesses involving sensitive technology, infrastructure or data. The analysis is not simply whether there is a foreign LP somewhere in the fund structure. Many US venture and private equity funds have foreign LPs. The practical questions are who the foreign LPs are, how much they own, whether they are related to each other, whether they are sovereign or state-linked, what rights they have, what information they receive, whether they sit on the Limited Partner Advisory Committee (LPAC), whether they can influence fund decisions and whether the fund structure keeps the fund passive for the relevant regulatory purposes.

Investor identity also matters as a matter of perception. Some rules are formally country-specific; others are not. For example, the US outbound investment regime identifies countries of concern. CFIUS is not framed in the same way for every part of its analysis, but CFIUS is an interagency US government national security process. It is not realistic to think investor identity, country sensitivity, sovereign status, strategic status or geopolitical context never affects how facts are viewed internally at the agency. In practice, those items certainly do.

The legal test may not always name a particular country. The practical risk analysis often still cares very much about which country, which investor, which sector and which rights are involved.

Control matters too

The third question is where control sits.

This is one of the most important distinctions in this area. Managers need to think separately about equity and control.

Equity asks whose money is being invested, who holds the economic interest and who is exposed to the investment.

Control asks who makes the investment decision, who controls the fund, who controls the manager, who sits on the investment committee, who has approval rights, who receives sensitive information, who can influence portfolio company decisions and who participates in governance.

Different rules care about these concepts differently.

Some rules focus heavily on capital flows and economic exposure. Others focus heavily on control, rights, information and decision-making. A fund may have foreign capital but US control. It may have US capital but non-US control. It may be organized in one jurisdiction but managed from another. It may have a non-US general partner (GP) but US investment professionals. It may have US persons participating in decisions for a non-US vehicle. It may have foreign LPs with only passive economics, or foreign LPs with significant approval or information rights.

There is another important definitional point. CFIUS and the US outbound investment rules do not use identical concepts of who is a US person. For example, US green card holders may be treated differently under the two regimes. A manager should not assume that a person who is treated as a US person for one regime is treated the same way for the other. These definitions need to be checked under the specific rules being applied.

These facts matter.

A manager should not assume that a Cayman fund is “non-US” for all relevant purposes merely because it is organized in Cayman. Nor should a manager assume that a Delaware fund is necessarily treated as US-controlled for every national security purpose if the economics and governance are effectively controlled by a foreign investor. Nor should a non-US manager assume that US person investment committee members can participate freely in sensitive China-related investment decisions merely because the vehicle is offshore.

The analysis often starts with a simple discipline: Identify the capital, control and information rights. Then see whether they match the regulatory posture the fund is trying to achieve.

CFIUS and ‘US person for CFIUS purposes’

For investments into US businesses, CFIUS is often the primary US national security regime managers need to consider.

At a high level, CFIUS reviews certain foreign investments in US businesses that may raise national security concerns. Historically, many people thought about CFIUS primarily in the context of foreign acquisitions of US defense contractors or other obviously sensitive businesses. That is no longer sufficient. CFIUS can be relevant to noncontrol investments in certain US businesses involving critical technology, critical infrastructure or sensitive personal data.

For private funds, one key question is whether the investor is a US person or a foreign person for CFIUS purposes.

The last words matter: for CFIUS purposes.

We are not asking whether the fund is “US” for tax purposes, securities law purposes, immigration purposes, branding purposes, office location purposes or ordinary commercial purposes. We are asking how the fund is treated under the CFIUS rules. This is particularly important because a green card holder is not treated the same as a US citizen for all CFIUS purposes, while the US outbound investment rules may treat green card holders as US persons. The definitions are not interchangeable.

There are several ways a fund structure may raise foreign person issues for CFIUS purposes.

• First, the fund may be foreign at the fund level. If the fund is organized outside the US and controlled by non-US persons, the starting point may be straightforward.
• Second, the fund may be foreign-controlled because the manager, GP, investment committee or other control persons are foreign persons. The fund’s domicile alone is not the whole answer. Control matters.
• Third, and often less discussed, a US-organized fund with US manager personnel may still raise foreign person issues if one or more foreign LPs effectively control the fund. This is a real issue, even if it is not always analyzed carefully.

The third point is often overlooked in articles about this topic. Consider a simple example. A Delaware fund has a US GP and US personnel, but a highly sensitive foreign strategic investor is the sole LP. It would be difficult to assume CFIUS would ignore that fact simply because the entity is a Delaware limited partnership and the nominal manager is US. A sole LP may have statutory rights, contractual rights, amendment rights, consent rights, removal rights, economic leverage or other powers under the limited partnership agreement. If the rule could be avoided merely by placing a sensitive foreign investor behind a US fund shell, the regime would be too easy to end-run.

Now consider a different case. A Delaware fund has several unrelated foreign LPs, none of whom owns a controlling position, none of whom can veto material decisions, none of whom has special information rights, and none of whom can control the GP, investment decisions or portfolio company rights. That is a very different fact pattern.

The practical lesson is not that foreign LPs are always a problem. The lesson is that foreign LP control is a problem, and it is sometimes underanalyzed.

A foreign LP is not the same thing as foreign LP control. But foreign LP control is real.

Passive economics versus covered rights

If a foreign or global fund wants to invest in a US business that may be sensitive for CFIUS purposes, the fund may sometimes have a choice. It can try to structure itself as a US-controlled vehicle, or it can invest in a more passive posture.

The passive posture can be useful, but it must be truly passive.

In ordinary venture capital practice, investors often expect a package of rights. These may include board seats, board observer rights, regular management updates, detailed information rights, technology updates, pro rata rights, consultation rights, consent rights and access to founders. Those rights may be commercially normal in many venture deals.

In a CFIUS-sensitive investment by a foreign or global fund, some of those rights may be exactly the problem.

The safer posture is generally limited to ordinary economic rights, basic tax reporting and high-level financial reporting. The investor should not receive a board seat, observer right, director nomination right, access to material nonpublic technical information, detailed technology roadmaps, engineering materials, source code, cybersecurity information, sensitive personal data, critical infrastructure information, or involvement in substantive decisions about sensitive technology, infrastructure or data.

This can be commercially awkward. Venture capital investors often want to help. They want access. They want to support the founder. They want to know what is happening. They want to be in the room.

But in a CFIUS-sensitive passive investment, being in the room may be the problem.

That does not mean the fund can receive no information. A fund needs ordinary financial information for valuation, audit, tax, reporting and administration. The distinction is between basic financial information and technical or operational information that creates sensitivity. A revenue number is not the same thing as an engineering roadmap. Audited financial statements are not the same thing as a board deck. A high-level business description is not the same thing as material nonpublic technical information.

In this context, passive should mean passive.

That may work if US sensitive investments are only a small portion of a global fund’s strategy. The fund may be willing to participate economically in those companies without the full venture capital rights package. It may not work if the fund’s core strategy is to lead US sensitive technology rounds and provide hands-on strategic support. In that case, the manager may need a different architecture, such as a genuinely US-controlled vehicle, rather than relying on passive rights.

Sometimes the answer is not a different vehicle. Sometimes the answer is a different investment posture.

OISP and US capital into China-related sensitive technologies

The US outbound investment regime raises a different kind of issue.

For purposes of this article, the details are less important than the practical fund formation point. The outbound rules focus on certain US person investments into China-related covered sectors, including areas such as semiconductors, quantum information technologies and AI. The regime distinguishes among prohibited transactions, notifiable transactions and transactions outside the covered categories.

The key point for fund managers is that US persons can have issues not only when they invest directly, but also when they invest indirectly through funds.

If a US investor commits capital to a Cayman, Singapore or other non-US fund that may invest into China-related covered sectors, the fund’s later investment activity can create a problem for that US investor. The investor may need to fit within an exception, receive a contractual assurance that its capital will not be used for certain investments or choose a vehicle that does not participate in certain categories of transactions.

Here again, definitions matter. The US outbound investment rules may treat US green card holders as US persons even though CFIUS may not treat them the same way for CFIUS purposes. Managers should not use one regime’s definition as a shortcut for the other.

That makes the Outbound Investment Security Program (OISP) a fund formation issue, a side letter issue, a parallel fund issue and an administrative issue. It is not merely a regulatory footnote for the investment team.

The US LP may say, in substance: “I can invest in your global fund, but I cannot be in a vehicle that will use my capital for prohibited transactions, and I may or may not be comfortable with notifiable transactions.”

Different investors may answer that question differently.

Some US institutional investors may be willing to participate in notifiable transactions, especially if they believe the return opportunity is significant, and the notice process is manageable. Others may want no exposure to notifiable or prohibited categories. Some non-US investors, including investors from jurisdictions closely aligned with the US, may voluntarily choose the more conservative vehicle even if the rule does not technically require them to do so. Their concern may be reputational, policy-driven, relationship-driven or simply a desire not to be close to the line.

This means a global manager cannot always solve OISP with one on/off switch. The structure may need multiple regulatory buckets.

Why excuse rights may not be enough

Historically, many legal, tax, regulatory and investor-specific issues in private funds were handled through excuse or exclusion rights. If a particular investor could not participate in a particular investment, the manager could excuse that investor from the investment. The rest of the fund would proceed.

Those rights still matter. They should still be included in fund documents. They may be very useful as rules evolve over time.

But in the current outbound investment environment, excuse rights may not always be enough.

Consider a non-US fund that intends to make China-related investments in sectors that may be prohibited for US persons. One might ask: Why not put all investors into one fund and simply excuse the US investors from those deals?

For many large US investors, that may feel too close to the sun. The rules are new, enforcement history is limited, the penalties can be significant, and the investor may not want to be in the same legal vehicle that is making the investments, even if the investor is technically excused from them. The cleaner answer may be a separate parallel fund that does not make those investments at all.

That distinction is very important.

Excuse rights are helpful, but they are not always sufficient. In the most sensitive settings, investors may want a different vehicle, not merely an excuse from a deal.

Parallel funds as regulatory routing tools

Parallel funds are not new. Fund managers have long used parallel funds for tax, regulatory, Employee Retirement Income Security Act (ERISA), treaty, domicile, currency, investor preference and administrative reasons.

What is changing is that parallel funds are increasingly being used as regulatory routing tools.

A global manager may have one parallel fund for investors that can participate in all global investments. It may have another parallel fund for investors that cannot participate in OISP-prohibited China-related investments. It may have another for investors that do not want exposure to notifiable transactions. It may have a separate RMB fund for local China investments. It may have a Delaware or US-controlled structure for certain US investments. It may use AIVs for particular investments. It may need to separate investors based on US person status, non-US status, China sensitivity, sovereign status, currency, local filing requirements or risk tolerance.

In simple fund structures, this may sound excessive. In complex global venture structures, it is increasingly where the action is.

Some global capital systems now involve four, five or six parallel vehicles or sleeves. That is not because managers enjoy complexity; it is because the capital, control and regulatory issues do not line up neatly in one vehicle.

The challenge is to make the structure flexible without making it unbounded. LPs need to know the ground rules when they commit. The manager needs enough authority to move quickly when a sensitive opportunity appears. The structure needs to be administrable by the manager, counsel, tax advisors, fund administrator and finance team.

The flexibility should be negotiated at formation. The execution often happens later.

Build the routing system before you need it

In complex global strategies, the fund documents should usually authorize the manager to create additional parallel funds, AIVs, feeder vehicles, sleeves or similar structures after closing.

Ideally, that authority is built into the limited partner agreement (LPA) and related documents at inception, often supported by powers of attorney. The goal is not to let the manager rewrite the bargain later. The goal is to agree on the ground rules in advance so the manager can implement the structure quickly when a deal requires it.

This is critical because sensitive investment opportunities often move quickly. The target company, co-investors, sellers, regulators and other parties will not necessarily wait while the manager goes back to every LP for real-time approval of complicated new documents. If the fund structure requires investor-by-investor consent each time a parallel vehicle is needed, the fund may lose the deal.

The documents should therefore consider authorizing the manager to:

• Create additional parallel funds, AIVs or similar vehicles after closing.
• Admit some or all investors to those vehicles.
• Allocate investments among vehicles.
• Transfer or allocate investments among parallel funds where appropriate.
• Make a particular investment only through selected vehicles.
• Classify investors by regulatory category or risk-tolerance bucket.
• Allow investors to make later elections where the issue is primarily an investor-specific risk tolerance question.
• Make capital calls only to the applicable vehicles or investors.
• Exclude investors or vehicles from particular investments.
• Withhold information where disclosure would create legal, regulatory, confidentiality, national security or portfolio company issues.
• Use powers of attorney to implement pre-agreed mechanics.
• Require investors to provide and update status information.

The art is in the ground rules.

LPs should understand how economics, expenses, follow-ons, recycling, defaults, capital calls, reporting and governance will work across the vehicles. The manager should not have unlimited discretion to move economics around in a way that changes the bargain; but the manager should have enough pre-agreed discretion to route capital properly when the regulatory facts require it.

A structure that is theoretically elegant but cannot be executed quickly is not a good structure.

Side letters are supporting tools, not the whole structure

Side letters remain important in this area. They may be used to obtain investor status information, provide investor-specific assurances, document OISP-related contractual assurances, limit information rights, address CFIUS concerns, create reporting exceptions, provide excuse rights or reflect an investor’s election into a particular regulatory bucket.

But side letters are not a substitute for the main fund architecture.

A side letter is bilateral. It can accommodate a particular investor. It should not be used to rewrite the entire fund’s investment program for everyone. A manager generally should not try to solve a fund-wide regulatory routing issue by promising one LP in a side letter that the entire fund will not make a category of investments, if that is inconsistent with the main fund documents, the expectations of other investors or the common bargain.

If the strategy requires one vehicle that can make a category of investments and another vehicle that cannot, that structure should usually be built into the fund architecture. The side letter can support the structure, but it should not be the structure.

This is especially important because the most sensitive issues may need to be administered across the full life of the fund. A promise that cannot be operationally tracked is dangerous. A side letter restriction that the deal team, finance team, administrator and investment committee do not understand may create more risk than it solves.

Information rights are usually curtailed

In complex global capital structures, information rights are usually more limited, not more robust.

This may surprise some investors – it should not.

If the structure is designed to keep certain investors passive, keep certain US persons out of certain non-US investment decisions, or avoid giving foreign investors rights that create CFIUS concern, the manager should not simultaneously give those investors extensive portfolio company information rights.

In practice, LPs in private funds generally do not receive material nonpublic technical information, board materials, export-controlled information, cybersecurity architecture, customer-level personal data or investment committee materials. That is especially true in sensitive global structures.

The more realistic issue is enhanced information. Strategic investors, corporate investors, funds of funds, large institutions or heavily negotiated investors may ask for portfolio company updates, operating data, technical descriptions, valuation support, co-investment materials, pipeline information or other information beyond ordinary fund reporting. In a complex regulatory structure, those rights may need to be limited.

The information package should match the regulatory posture.

A passive investor structure can be weakened if the investor receives information that makes it look less passive. A foreign LP that is supposed to be passive for CFIUS purposes should not receive detailed technical information about US sensitive portfolio companies. A US person that is not supposed to participate in a China-related sensitive investment should not receive materials that make it look like that person is involved in the decision.

The documents should preserve the manager’s ability to withhold or limit information where disclosure would create legal, regulatory, national security, sanctions, export control, data, confidentiality, material nonpublic information or portfolio company issues.

This should not be viewed as evasive; it is responsible administration.

LPACs may need to follow the capital

LPAC rights create a related issue.

Historically, managers often thought of the LPAC as a fund-level body. It received information, reviewed conflicts, approved waivers, considered valuation issues, approved affiliate transactions, reviewed fund term extensions and addressed other governance matters for the fund as a whole.

In a simple fund, that model works.

In a complex global capital structure, a single all-purpose LPAC may not work for every matter.

If one parallel fund is permitted to participate in an OISP-sensitive China-related investment and another parallel fund is specifically designed not to participate in those investments, the LPAC members associated with the nonparticipating fund may not be the right people to receive information or provide approvals for that investment. In some cases, involving them could undermine the regulatory architecture.

For example, assume a parallel fund exists specifically so US person investors do not participate in OISP-prohibited investments. If a different parallel fund is making one of those investments, and the manager needs an approval related to that deal, such as a single-investment-limit override, a conflict approval or another governance matter, it may be inappropriate for US person LPAC members from the nonparticipating vehicle to review and approve that matter.

This is why we are increasingly seeing sub-LPACs, vehicle-specific LPACs or deal-specific governance processes in complex global fund structures. That was much less common historically but is becoming more relevant because the governance structure needs to match the investment structure.

If the capital is separated, the governance may need to be separated too.

A structure that separates capital but leaves all approval rights, information rights and LPAC processes pooled together may not solve the problem it was designed to solve.

A practical global venture example

Consider a global venture manager based primarily in Singapore. The senior team includes several Singapore nationals and one PRC national. The manager has a strong reputation and access to capital from US institutional investors, Asian sovereign investors, China-related investors resident outside China with dollar capital and RMB investors inside China. The manager wants to invest globally, including in US technology companies and China-related technology companies. Some of those investments may involve AI, semiconductors, life sciences, data or other sensitive sectors.

A single fund may not be enough.

One parallel fund might participate in all global deals for investors that do not have OISP concerns. Another parallel fund might participate in all deals except OISP-prohibited China-related investments. A third might avoid both prohibited and notifiable China-related investments for investors with a more conservative risk tolerance. Some US investors may be comfortable with notifiable transactions; others may not. Some non-US investors may voluntarily elect the more conservative path because of their own institutional, policy or relationship concerns.

The same manager might also have an RMB fund inside China for local RMB investments in companies intended for local listing paths. That brings a different set of China local law, currency, regulatory, listing and historical dollar/RMB fund issues. Those issues have not disappeared merely because US inbound and outbound regimes have become more prominent.

The hardest piece may be US sensitive investments.

If the Singapore-led platform has a genuinely US-controlled affiliate or vehicle, perhaps under a brand license or carefully structured economic sharing arrangement, that may open a path for a US person fund for CFIUS purposes. But the control needs to be real. It cannot be a label. If the investment decisions are still being made by non-US persons, the structure may not accomplish what it is intended to accomplish.

If the platform does not have a genuinely US-controlled vehicle, it may still be able to invest in certain US sensitive companies, but only in a passive posture. That may mean no board seat, no observer right, no material nonpublic technical information, no special access to sensitive information and no substantive decision-making rights. The fund may receive ordinary economic rights, tax reporting and basic financial statements, but not the rights a venture investor might ordinarily seek.

That may be acceptable if US sensitive deals are a small portion of the strategy. It may be inadequate if the manager’s core investment thesis requires active involvement in US sensitive technology companies.

This example illustrates the broader point. The right structure depends on the strategy, the investors, the control persons, the target sectors and the manager’s willingness to adjust investment posture.

China and RMB capital still matter

Although this article focuses heavily on US inbound and outbound rules, managers should not forget that China-side issues still matter.

A fund investing into China-related companies may need to consider China foreign investment access rules, negative lists, security review, data rules, sector regulation, currency controls, local approvals, local listing paths, RMB funds, dollar funds, offshore holding structures and the long history of structuring issues between offshore capital and onshore China opportunities.

Similarly, PRC investors, RMB capital, China-based managers, PRC nationals and China technology moving offshore may raise their own issues. A manager with both dollar capital and RMB capital may be running parallel systems that are not merely tax or currency variants. They may have different investor bases, different investment paths, different regulatory requirements and different exit strategies.

The practical point is not that every global fund needs to become a China law treatise. The point is that US regulatory regimes are only part of the picture. A manager deploying capital globally needs to understand both sides of the capital flow.

Administration is where the structure succeeds or fails

Sophisticated fund structures can fail in administration.

It is one thing for the LPA to authorize parallel funds, AIVs, sleeves, investor exclusions, information limitations and sub-LPACs. It is another thing for the manager to operate that structure correctly for a decade.

The manager needs systems to classify investors. It needs to know which investors are US persons, which investors have OISP restrictions, which investors have elected into conservative buckets, which investors are foreign persons for relevant purposes, which investors are sovereign or state-linked, and which investors have side letter rights affecting information, reporting, excuse or participation.

The manager also needs to classify deals. Before signing a term sheet, the investment team should know whether the target may raise CFIUS issues, OISP issues, sanctions issues, export control issues, data issues, China local law issues or other regulatory concerns. The team should know which vehicle can invest, which investors can participate, which LPAC or sub-LPAC process applies, what information can be shared and whether regulatory counsel should be involved before the deal moves forward.

Capital calls need to match the structure. If one parallel fund participates and another does not, the capital call notices, equalization, expense allocations, follow-on reserves, recycling, financial statements and reporting need to reflect that.

Information flows need to match the structure. Investor relations should not send technical information to an investor that should not receive it. LPAC materials should not go to the wrong group. Side letter reporting should not override regulatory restrictions.

Governance needs to match the structure. The right LPAC or sub-LPAC should approve the right matter. US persons should not participate in decisions they should not be involved in. Foreign LPs should not receive influence or information that undercuts the fund’s position.

The administrator, finance team, deal team, investor relations team and counsel all need to understand the operating model.

In complex global structures, capital routing, control routing, information routing and governance routing are all part of the same system.

Practical drafting and administration points

Several drafting and administration points deserve careful attention:

• Identify the strategy’s sensitivity spectrum at formation. A fund investing in ordinary consumer businesses may need less regulatory architecture than a fund investing in AI, semiconductors, quantum, life sciences, cybersecurity, data or other sensitive sectors.
• Distinguish equity from control. Whose capital is exposed and who controls the decision are different questions. Both matter.
• Analyze whether the fund is a US person for CFIUS purposes, not merely whether it is organized in the US or has US personnel.
• Remember that CFIUS and OISP do not use identical US person concepts. Green card holders may be treated differently under the two regimes.
• Do not ignore foreign LP control. A foreign LP is not the same thing as foreign LP control, but foreign LP control is real.
• Recognize that OISP can create issues for US LPs investing indirectly through a non-US fund. The fund’s investment activity may create consequences for the investor.
• Do not assume excuse rights will solve every problem. In sensitive OISP structures, a separate parallel vehicle may be more appropriate than participation in the same fund with an excuse.
• Build parallel fund, AIV and sleeve authority into the documents at inception. The manager may need to move quickly when a sensitive deal appears.
• Use powers of attorney carefully but effectively. The documents should establish the ground rules at formation and allow implementation later without real-time investor consent where appropriate.
• Make side letters administrable. Side letters can support the structure, but they should not be used as a substitute for fund-wide architecture.
• Preserve the right to withhold information where disclosure would create legal, regulatory, national security, confidentiality, data, export control, sanctions or portfolio company concerns.
• Be careful with LPAC rights. In complex structures, sub-LPACs or vehicle-specific LPACs may be needed.
• If relying on a passive posture for a CFIUS-sensitive US investment, make the posture truly passive. Ordinary economics and basic financial reporting are one thing. Board seats, observer rights, technical information and substantive decision-making rights are very different.
• Coordinate portfolio company documents with the fund structure. Rights can appear in investor rights agreements, voting agreements, side letters, management rights letters and observer letters, not only in the purchase agreement.
• Require investors to provide and update information needed to classify them for regulatory purposes.
• Involve regulatory counsel before signing term sheets for sensitive investments, not after the commercial deal is already set.

Conclusion

Global private funds can still raise global capital and deploy capital globally. But in complex regulatory times, managers need more deliberate architecture.

For many global venture capital and private equity managers, the key question is no longer simply whether the fund is Delaware or Cayman, whether investors receive a K-1 or whether the fund has authority to form an AIV. The question is how capital, control, information and governance move through the structure.

A fund with US investors investing into China-related sensitive sectors may need one answer. A fund with foreign investors investing into US sensitive businesses may need another. A global platform investing across the US, China, Singapore and other markets may need several answers at once.

The best structures are not necessarily the simplest structures. They are the structures that let the manager keep investing without giving the wrong investor the wrong exposure, the wrong person the wrong control right, the wrong LPAC the wrong approval role, or the wrong recipient the wrong information.

This is not a reason to avoid global investing. It is a reason to structure it carefully.

In complex global fund formation, the documents should not merely describe the fund. They should create the routing system the manager will need to operate the fund responsibly over time.